×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SABS – sab biotherapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SABS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/2
09:00 am
sabs
SAB Biotherapeutics (SABS) is now covered by Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock.
Low
Report
SAB Biotherapeutics (SABS) is now covered by Rodman & Renshaw. They set a "buy" rating and a $13.00 price target on the stock.
3/19
04:55 pm
sabs
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Low
Report
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
3/19
04:01 pm
sabs
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Low
Report
SAB BIO Announces Closing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
3/17
10:46 pm
sabs
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
SAB BIO Announces Pricing of $85 Million Public Offering of Common Stock and Pre-Funded Warrants
3/17
04:43 pm
sabs
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
Medium
Report
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants [Yahoo! Finance]
3/17
04:15 pm
sabs
SAB Biotherapeutics announces public stock offering; shares down [Seeking Alpha]
Medium
Report
SAB Biotherapeutics announces public stock offering; shares down [Seeking Alpha]
3/17
04:01 pm
sabs
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Medium
Report
SAB BIO Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
3/14
06:59 am
sabs
SAB Biotherapeutics (SABS) was downgraded by Zacks Research from "hold" to "strong sell".
Medium
Report
SAB Biotherapeutics (SABS) was downgraded by Zacks Research from "hold" to "strong sell".
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/25
04:35 pm
sabs
Form 4 SAB Biotherapeutics, For: Mar 24 Filed by: Kropotova Alexandra
Low
Report
Form 4 SAB Biotherapeutics, For: Mar 24 Filed by: Kropotova Alexandra
3/23
04:26 pm
sabs
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
3/19
06:02 am
sabs
Form 8-K SAB Biotherapeutics, For: Mar 17
Low
Report
Form 8-K SAB Biotherapeutics, For: Mar 17
3/19
06:02 am
sabs
Form 424B5 SAB Biotherapeutics,
Low
Report
Form 424B5 SAB Biotherapeutics,
3/17
04:01 pm
sabs
Form 424B5 SAB Biotherapeutics,
Medium
Report
Form 424B5 SAB Biotherapeutics,
3/11
04:43 pm
sabs
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A SAB Biotherapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
3/10
07:36 am
sabs
Form 8-K SAB Biotherapeutics, For: Mar 10
Medium
Report
Form 8-K SAB Biotherapeutics, For: Mar 10
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: